Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;38(8):865-878.
doi: 10.14670/HH-18-600. Epub 2023 Feb 27.

Prognostic factors of breast phyllodes tumors

Eunah Shin  1 , Ja Seung Koo  2
Affiliations
Review

Prognostic factors of breast phyllodes tumors

Eunah Shin et al. Histol Histopathol. 2023 Aug.

Abstract

Background: Phyllodes tumor (PT) is a relatively rare breast tumor, accounting for <1% of all breast tumors.

Main body: Adjuvant therapy with chemotherapy or radiation therapy, other than surgical excision, has not been established yet. PT, similar to other breast tumors, is classified as benign, borderline, and malignant according to the World Health Organization classification system, depending on stromal cellularity, stromal atypia, mitotic activity, stromal overgrowth, and tumor border. However, this histological grading system cannot effectively or fully reflect the clinical prognosis of PT. Several studies have investigated prognostic factors for PT as some PTs recur or metastasize to distant sites, and thus, prediction of prognosis is clinically imperative.

Conclusion: This review discusses clinicopathological factors, immunohistochemical markers, and molecular factors that have been investigated in previous studies to have an impact on the clinical prognosis of PT.

PubMed Disclaimer

References

    1. Abe M., Miyata S., Nishimura S., Iijima K., Makita M., Akiyama F. and Iwase T. (2011). Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer 18, 268-272. - PubMed
    1. Abusalem O.T. and Al-Masri A. (2011). Phyllodes tumors of the breast. Mater Sociomed. 23, 200-205. - PMC - PubMed
    1. Al-Masri M., Darwazeh G., Sawalhi S., Mughrabi A., Sughayer M. and Al-Shatti M. (2012). Phyllodes tumor of the breast: role of CD10 in predicting metastasis. Ann. Surg. Oncol. 19, 1181-1184. - PubMed
    1. Asoglu O., Ugurlu M.M., Blanchard K., Grant C.S., Reynolds C., Cha S.S. and Donohue J.H. (2004). Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann. Surg. Oncol. 11, 1011-1017. - PubMed
    1. Barrio A.V., Clark B.D., Goldberg J.I., Hoque L.W., Bernik S.F., Flynn L.W., Susnik B., Giri D., Polo K., Patil S. and Van Zee K.J. (2007). Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann. Surg. Oncol. 14, 2961-2970. - PubMed

LinkOut - more resources